# Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer

> **NCT01081873** · — · COMPLETED · sponsor: **Abbott** · enrollment: 2717 (actual)

## Conditions studied

- Prostatic Neoplasm

## Interventions

- **DRUG:** leuprolide (Lucrin/Lucrin-Tri-depot)

## Key facts

- **NCT ID:** NCT01081873
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 2717 (ACTUAL)
- **Last updated:** 2012-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01081873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01081873, "Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01081873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*